Providing women with access to better breast cancer screening Vara raises €4.5 million
Summary
The purpose-driven startup works with local clinics to give women access to life-saving treatment and makes screening more effective with its AI approach. It follows quite an impressive year for the impact-driven team, who we interviewed in the summer, as they expanded into international markets, published multiple peer-reviewed papers and launched the largest real-world clinical breast cancer screening trial of its kind. Vara fits perfectly with EQT’s thematic investment approach, and we look forward to the exciting journey ahead.” This funding also aligns with the launch of a nationwide clinical study of AI and workflow software in breast cancer screening, with the expected recruitment of 400,000 screening-age women. From its unique tech and AI approach to its deep integration with German centres, and its strong partnerships with international providers, Vara is an innovative startup with great purpose. It’s already underpinned by a growing body of peer-reviewed evidence and backed by clinical and health experts, and through its groundbreaking prospective study coupled with this latest investment, Vara is in a strong position to achieve its life-saving mission.”
Funding
Review available funding amount, funding date, investors, and linked company information related to Providing women with access to better breast cancer screening Vara raises €4.5 million in the interactive ISVWorld profile.